

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin filament-based movement (GO:0030048) | 8.57153743 |
| 2 | striated muscle contraction (GO:0006941) | 7.99179853 |
| 3 | myofibril assembly (GO:0030239) | 7.43282456 |
| 4 | regulation of relaxation of muscle (GO:1901077) | 7.35563727 |
| 5 | sarcomere organization (GO:0045214) | 7.28480821 |
| 6 | skeletal muscle fiber development (GO:0048741) | 6.98260575 |
| 7 | response to muscle activity (GO:0014850) | 6.97469807 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.93981308 |
| 9 | creatine metabolic process (GO:0006600) | 6.74664389 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.45643627 |
| 11 | plasma membrane repair (GO:0001778) | 6.37511944 |
| 12 | response to inactivity (GO:0014854) | 6.36288621 |
| 13 | myotube cell development (GO:0014904) | 6.25905673 |
| 14 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.05331120 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.03271638 |
| 16 | muscle contraction (GO:0006936) | 6.02266296 |
| 17 | actomyosin structure organization (GO:0031032) | 5.63965589 |
| 18 | skeletal muscle adaptation (GO:0043501) | 5.60620317 |
| 19 | positive regulation of myotube differentiation (GO:0010831) | 5.51760407 |
| 20 | cardiac myofibril assembly (GO:0055003) | 5.38232656 |
| 21 | muscle system process (GO:0003012) | 5.34788488 |
| 22 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.29514422 |
| 23 | cardiac muscle contraction (GO:0060048) | 5.26318441 |
| 24 | skeletal muscle tissue development (GO:0007519) | 5.18799161 |
| 25 | glycogen catabolic process (GO:0005980) | 5.09236173 |
| 26 | skeletal muscle tissue regeneration (GO:0043403) | 4.96548713 |
| 27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.90186033 |
| 28 | muscle fiber development (GO:0048747) | 4.78012211 |
| 29 | glucan catabolic process (GO:0009251) | 4.77676639 |
| 30 | muscle cell fate commitment (GO:0042693) | 4.72586028 |
| 31 | regulation of cell communication by electrical coupling (GO:0010649) | 4.72563327 |
| 32 | glucan biosynthetic process (GO:0009250) | 4.59443212 |
| 33 | glycogen biosynthetic process (GO:0005978) | 4.59443212 |
| 34 | muscle cell cellular homeostasis (GO:0046716) | 4.57972356 |
| 35 | muscle organ development (GO:0007517) | 4.57227984 |
| 36 | striated muscle atrophy (GO:0014891) | 4.54809669 |
| 37 | muscle structure development (GO:0061061) | 4.53042167 |
| 38 | cellular polysaccharide catabolic process (GO:0044247) | 4.46596389 |
| 39 | striated muscle adaptation (GO:0014888) | 4.36761454 |
| 40 | NADH metabolic process (GO:0006734) | 4.21357278 |
| 41 | myoblast fusion (GO:0007520) | 4.09864596 |
| 42 | muscle organ morphogenesis (GO:0048644) | 4.06235314 |
| 43 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.05489826 |
| 44 | regulation of actin filament-based movement (GO:1903115) | 4.03603467 |
| 45 | polysaccharide catabolic process (GO:0000272) | 4.00993932 |
| 46 | muscle atrophy (GO:0014889) | 4.00234069 |
| 47 | cardiac muscle hypertrophy (GO:0003300) | 4.00038122 |
| 48 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.96136722 |
| 49 | striated muscle cell development (GO:0055002) | 3.82115281 |
| 50 | striated muscle hypertrophy (GO:0014897) | 3.81054699 |
| 51 | positive regulation of myoblast differentiation (GO:0045663) | 3.80821325 |
| 52 | regulation of striated muscle contraction (GO:0006942) | 3.80095713 |
| 53 | regulation of myoblast differentiation (GO:0045661) | 3.77530670 |
| 54 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.71788870 |
| 55 | negative regulation of protein localization to cell surface (GO:2000009) | 3.70968432 |
| 56 | fructose metabolic process (GO:0006000) | 3.65725001 |
| 57 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.65593736 |
| 58 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.65593736 |
| 59 | response to activity (GO:0014823) | 3.62473155 |
| 60 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.61424851 |
| 61 | glycogen metabolic process (GO:0005977) | 3.61416173 |
| 62 | myotube differentiation (GO:0014902) | 3.59583314 |
| 63 | striated muscle tissue development (GO:0014706) | 3.57080995 |
| 64 | cellular glucan metabolic process (GO:0006073) | 3.53885987 |
| 65 | glucan metabolic process (GO:0044042) | 3.53885987 |
| 66 | muscle adaptation (GO:0043500) | 3.53116492 |
| 67 | regulation of myotube differentiation (GO:0010830) | 3.51634411 |
| 68 | muscle tissue morphogenesis (GO:0060415) | 3.51286306 |
| 69 | muscle hypertrophy (GO:0014896) | 3.49147458 |
| 70 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.46872850 |
| 71 | gluconeogenesis (GO:0006094) | 3.44107391 |
| 72 | cardiac muscle cell development (GO:0055013) | 3.40398680 |
| 73 | skeletal muscle cell differentiation (GO:0035914) | 3.39824442 |
| 74 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.39371790 |
| 75 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.39371790 |
| 76 | muscle cell development (GO:0055001) | 3.36879871 |
| 77 | negative regulation of cell size (GO:0045792) | 3.35957306 |
| 78 | 2-oxoglutarate metabolic process (GO:0006103) | 3.35725293 |
| 79 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.26304705 |
| 80 | regulation of skeletal muscle fiber development (GO:0048742) | 3.23707441 |
| 81 | cardiac cell development (GO:0055006) | 3.19530480 |
| 82 | regulation of muscle system process (GO:0090257) | 3.16217136 |
| 83 | muscle tissue development (GO:0060537) | 3.15542617 |
| 84 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.15489502 |
| 85 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.14105891 |
| 86 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.12182159 |
| 87 | regulation of sarcomere organization (GO:0060297) | 3.11890140 |
| 88 | hexose biosynthetic process (GO:0019319) | 3.07278394 |
| 89 | carnitine shuttle (GO:0006853) | 3.05907063 |
| 90 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.03033182 |
| 91 | negative regulation of muscle contraction (GO:0045932) | 3.01994536 |
| 92 | adult heart development (GO:0007512) | 2.99695999 |
| 93 | regulation of muscle contraction (GO:0006937) | 2.99571147 |
| 94 | syncytium formation (GO:0006949) | 2.99087175 |
| 95 | actin-myosin filament sliding (GO:0033275) | 13.9121306 |
| 96 | muscle filament sliding (GO:0030049) | 13.9121306 |
| 97 | skeletal muscle contraction (GO:0003009) | 12.3930207 |
| 98 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 11.6273240 |
| 99 | actin-mediated cell contraction (GO:0070252) | 11.4281462 |
| 100 | regulation of skeletal muscle contraction (GO:0014819) | 11.1558450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.92353354 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.39259284 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.03038722 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.98245505 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.77513088 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.72277487 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.66942462 |
| 8 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.66942462 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.61039340 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.60019632 |
| 11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.44365398 |
| 12 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 2.35629590 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18832405 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.15287415 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.14071178 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10915863 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.10216751 |
| 18 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.98645620 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.97755586 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97511585 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.90303582 |
| 22 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.89578390 |
| 23 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.87614414 |
| 24 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.85766263 |
| 25 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.72197061 |
| 26 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.67136476 |
| 27 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.63550020 |
| 28 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.63233696 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61737853 |
| 30 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.60809986 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.59521399 |
| 32 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.58353039 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56962976 |
| 34 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.53666853 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52426632 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50483905 |
| 37 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.50167241 |
| 38 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47266752 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44366101 |
| 40 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42848161 |
| 41 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.41942952 |
| 42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41219449 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40679247 |
| 44 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.37316502 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37034381 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36948542 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36884803 |
| 48 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32453656 |
| 49 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32095213 |
| 50 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.31748874 |
| 51 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.30578537 |
| 52 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.29646976 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25264825 |
| 54 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.25242353 |
| 55 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.23517438 |
| 56 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23208305 |
| 57 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.22600160 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21774327 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19437104 |
| 60 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15597797 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15046076 |
| 62 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12806893 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 1.11214965 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.10511638 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10113350 |
| 66 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.10099753 |
| 67 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.08140420 |
| 68 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.07444710 |
| 69 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07306212 |
| 70 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07220635 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05796406 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05347980 |
| 73 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03149351 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02619309 |
| 75 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.01119131 |
| 76 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99811288 |
| 77 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.99707158 |
| 78 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.99707158 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99527841 |
| 80 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98583954 |
| 81 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97659048 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97545971 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96550726 |
| 84 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95693955 |
| 85 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95081572 |
| 86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94982427 |
| 87 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.94680685 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92042435 |
| 89 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.91662183 |
| 90 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91585877 |
| 91 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.88859589 |
| 92 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88796996 |
| 93 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88259617 |
| 94 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85570406 |
| 95 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84719764 |
| 96 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.84604602 |
| 97 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.84268184 |
| 98 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.84254865 |
| 99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.84238497 |
| 100 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.84206603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.90802623 |
| 2 | MP0000751_myopathy | 6.48580566 |
| 3 | MP0000749_muscle_degeneration | 6.10095049 |
| 4 | MP0003646_muscle_fatigue | 5.68280025 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.17579663 |
| 6 | MP0002106_abnormal_muscle_physiology | 3.85457068 |
| 7 | MP0000759_abnormal_skeletal_muscle | 3.79257256 |
| 8 | MP0000747_muscle_weakness | 3.75487107 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.65920921 |
| 10 | MP0005369_muscle_phenotype | 3.35960874 |
| 11 | MP0005451_abnormal_body_composition | 3.30632649 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.27191636 |
| 13 | MP0002269_muscular_atrophy | 3.11439762 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.92358327 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.90866626 |
| 16 | MP0004233_abnormal_muscle_weight | 2.88817325 |
| 17 | MP0002332_abnormal_exercise_endurance | 2.74590280 |
| 18 | MP0000733_abnormal_muscle_development | 2.62703100 |
| 19 | MP0005330_cardiomyopathy | 2.61421619 |
| 20 | MP0004130_abnormal_muscle_cell | 2.50148128 |
| 21 | MP0002108_abnormal_muscle_morphology | 2.43766721 |
| 22 | MP0000013_abnormal_adipose_tissue | 2.02269608 |
| 23 | MP0002972_abnormal_cardiac_muscle | 1.97240029 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 1.77896499 |
| 25 | MP0004270_analgesia | 1.69186416 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.66554499 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.60938933 |
| 28 | MP0004484_altered_response_of | 1.59113478 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.58600736 |
| 30 | MP0004510_myositis | 1.52520493 |
| 31 | MP0004215_abnormal_myocardial_fiber | 1.41280870 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.31910312 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.25123815 |
| 34 | MP0006138_congestive_heart_failure | 1.23192255 |
| 35 | MP0005266_abnormal_metabolism | 1.21936875 |
| 36 | MP0005385_cardiovascular_system_phenoty | 1.14812348 |
| 37 | MP0001544_abnormal_cardiovascular_syste | 1.14812348 |
| 38 | MP0000003_abnormal_adipose_tissue | 1.13587767 |
| 39 | MP0002971_abnormal_brown_adipose | 1.13298130 |
| 40 | MP0005275_abnormal_skin_tensile | 1.08298126 |
| 41 | MP0005375_adipose_tissue_phenotype | 0.98247125 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 0.97180590 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 0.95105091 |
| 44 | MP0002822_catalepsy | 0.93354694 |
| 45 | MP0001661_extended_life_span | 0.91403949 |
| 46 | MP0010030_abnormal_orbit_morphology | 0.91358906 |
| 47 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82145449 |
| 48 | MP0005666_abnormal_adipose_tissue | 0.81252832 |
| 49 | MP0003137_abnormal_impulse_conducting | 0.79414448 |
| 50 | MP0002249_abnormal_larynx_morphology | 0.73029031 |
| 51 | MP0004134_abnormal_chest_morphology | 0.72939286 |
| 52 | MP0001299_abnormal_eye_distance/ | 0.69985029 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 0.69546543 |
| 54 | MP0005503_abnormal_tendon_morphology | 0.69329081 |
| 55 | MP0005670_abnormal_white_adipose | 0.68352046 |
| 56 | MP0003879_abnormal_hair_cell | 0.68278827 |
| 57 | MP0000266_abnormal_heart_morphology | 0.65241238 |
| 58 | MP0003045_fibrosis | 0.61947304 |
| 59 | MP0003279_aneurysm | 0.58238851 |
| 60 | MP0003828_pulmonary_edema | 0.56782008 |
| 61 | MP0009250_abnormal_appendicular_skeleto | 0.54804752 |
| 62 | MP0002114_abnormal_axial_skeleton | 0.54160827 |
| 63 | MP0004085_abnormal_heartbeat | 0.53588094 |
| 64 | MP0008775_abnormal_heart_ventricle | 0.51186240 |
| 65 | MP0002896_abnormal_bone_mineralization | 0.49263753 |
| 66 | MP0001346_abnormal_lacrimal_gland | 0.48147887 |
| 67 | MP0009672_abnormal_birth_weight | 0.45015342 |
| 68 | MP0000762_abnormal_tongue_morphology | 0.44435274 |
| 69 | MP0004272_abnormal_basement_membrane | 0.43820946 |
| 70 | MP0002128_abnormal_blood_circulation | 0.42468651 |
| 71 | MP0003948_abnormal_gas_homeostasis | 0.41635192 |
| 72 | MP0000534_abnormal_ureter_morphology | 0.40025679 |
| 73 | MP0009384_cardiac_valve_regurgitation | 0.37713790 |
| 74 | MP0005166_decreased_susceptibility_to | 0.37265798 |
| 75 | MP0000767_abnormal_smooth_muscle | 0.35657985 |
| 76 | MP0001958_emphysema | 0.35649382 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.35436258 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.34925529 |
| 79 | MP0000372_irregular_coat_pigmentation | 0.34380230 |
| 80 | MP0004858_abnormal_nervous_system | 0.33743831 |
| 81 | MP0001943_abnormal_respiration | 0.33617251 |
| 82 | MP0005595_abnormal_vascular_smooth | 0.32911725 |
| 83 | MP0005083_abnormal_biliary_tract | 0.32116883 |
| 84 | MP0008569_lethality_at_weaning | 0.30587857 |
| 85 | MP0001542_abnormal_bone_strength | 0.28832515 |
| 86 | MP0001849_ear_inflammation | 0.28505907 |
| 87 | MP0005535_abnormal_body_temperature | 0.28223067 |
| 88 | MP0005452_abnormal_adipose_tissue | 0.28148360 |
| 89 | MP0002734_abnormal_mechanical_nocicepti | 0.28083580 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.25118040 |
| 91 | MP0003385_abnormal_body_wall | 0.24750128 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.24683454 |
| 93 | MP0006276_abnormal_autonomic_nervous | 0.24312047 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.24125676 |
| 95 | MP0004197_abnormal_fetal_growth/weight/ | 0.23777236 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.22335594 |
| 97 | MP0005334_abnormal_fat_pad | 0.20685546 |
| 98 | MP0005165_increased_susceptibility_to | 0.19919066 |
| 99 | MP0004142_abnormal_muscle_tone | 0.19255898 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.19165384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.91705850 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.70232181 |
| 3 | Distal arthrogryposis (HP:0005684) | 9.23386069 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 7.82787510 |
| 5 | Exercise-induced myalgia (HP:0003738) | 7.67752143 |
| 6 | Round ear (HP:0100830) | 7.26128507 |
| 7 | Ulnar deviation of the wrist (HP:0003049) | 6.92127343 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 6.60745077 |
| 9 | Calcaneovalgus deformity (HP:0001848) | 6.16514927 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.77830692 |
| 11 | Myopathic facies (HP:0002058) | 5.65484919 |
| 12 | Deformed tarsal bones (HP:0008119) | 5.48810415 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 5.28525038 |
| 14 | Absent phalangeal crease (HP:0006109) | 5.03241855 |
| 15 | EMG: myopathic abnormalities (HP:0003458) | 4.72407182 |
| 16 | Muscle fiber splitting (HP:0003555) | 4.59868479 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 4.29878538 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 4.27043620 |
| 19 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.23304585 |
| 20 | Malignant hyperthermia (HP:0002047) | 4.22625922 |
| 21 | Abnormal finger flexion creases (HP:0006143) | 4.19982068 |
| 22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.10971682 |
| 23 | Neck muscle weakness (HP:0000467) | 4.10507575 |
| 24 | Rhabdomyolysis (HP:0003201) | 3.98727200 |
| 25 | Myoglobinuria (HP:0002913) | 3.91478728 |
| 26 | Increased connective tissue (HP:0009025) | 3.85354569 |
| 27 | Subaortic stenosis (HP:0001682) | 3.85320211 |
| 28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.85320211 |
| 29 | Fetal akinesia sequence (HP:0001989) | 3.82205474 |
| 30 | Abnormality of the calcaneus (HP:0008364) | 3.80911465 |
| 31 | Difficulty running (HP:0009046) | 3.66754575 |
| 32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.51129902 |
| 33 | Asymmetric septal hypertrophy (HP:0001670) | 3.48171258 |
| 34 | Rimmed vacuoles (HP:0003805) | 3.39073495 |
| 35 | Muscle stiffness (HP:0003552) | 3.32463771 |
| 36 | Myotonia (HP:0002486) | 3.23758484 |
| 37 | Distal lower limb muscle weakness (HP:0009053) | 3.11399996 |
| 38 | Sudden death (HP:0001699) | 3.09670910 |
| 39 | Metatarsus adductus (HP:0001840) | 3.04164970 |
| 40 | Hip contracture (HP:0003273) | 2.93378468 |
| 41 | Popliteal pterygium (HP:0009756) | 2.86190119 |
| 42 | Frequent falls (HP:0002359) | 2.85672389 |
| 43 | Breech presentation (HP:0001623) | 2.76763716 |
| 44 | Areflexia of lower limbs (HP:0002522) | 2.74199797 |
| 45 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.73697232 |
| 46 | EMG: neuropathic changes (HP:0003445) | 2.67508644 |
| 47 | Gowers sign (HP:0003391) | 2.65729684 |
| 48 | Bulbar palsy (HP:0001283) | 2.59550963 |
| 49 | Generalized muscle weakness (HP:0003324) | 2.59284877 |
| 50 | Trismus (HP:0000211) | 2.57885670 |
| 51 | Slender build (HP:0001533) | 2.52344012 |
| 52 | Abnormality of the neuromuscular junction (HP:0003398) | 2.47233447 |
| 53 | Fatigable weakness (HP:0003473) | 2.47233447 |
| 54 | Weak cry (HP:0001612) | 2.44970353 |
| 55 | Scapular winging (HP:0003691) | 2.36533316 |
| 56 | Limb-girdle muscle atrophy (HP:0003797) | 2.34771703 |
| 57 | Spinal rigidity (HP:0003306) | 2.32740019 |
| 58 | Bundle branch block (HP:0011710) | 2.32277447 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 2.32114186 |
| 60 | Ulnar deviation of finger (HP:0009465) | 2.10715733 |
| 61 | Ventricular tachycardia (HP:0004756) | 2.07379617 |
| 62 | Hyperkalemia (HP:0002153) | 2.05681513 |
| 63 | Limited hip movement (HP:0008800) | 2.03061212 |
| 64 | Dilated cardiomyopathy (HP:0001644) | 2.02650073 |
| 65 | Abnormality of placental membranes (HP:0011409) | 2.02267714 |
| 66 | Amniotic constriction ring (HP:0009775) | 2.02267714 |
| 67 | Nemaline bodies (HP:0003798) | 10.1168839 |
| 68 | Difficulty climbing stairs (HP:0003551) | 1.97824388 |
| 69 | Aplasia of the musculature (HP:0100854) | 1.92763366 |
| 70 | Progressive muscle weakness (HP:0003323) | 1.92317437 |
| 71 | Waddling gait (HP:0002515) | 1.87966847 |
| 72 | Lipoatrophy (HP:0100578) | 1.85549316 |
| 73 | Muscular dystrophy (HP:0003560) | 1.85059996 |
| 74 | Long clavicles (HP:0000890) | 1.80908421 |
| 75 | Adducted thumb (HP:0001181) | 1.78840388 |
| 76 | Type 2 muscle fiber atrophy (HP:0003554) | 1.77895744 |
| 77 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.76184415 |
| 78 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.73840097 |
| 79 | Abnormality of the foot musculature (HP:0001436) | 1.72629120 |
| 80 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.72503905 |
| 81 | Proximal amyotrophy (HP:0007126) | 1.71665954 |
| 82 | Lower limb amyotrophy (HP:0007210) | 1.71332016 |
| 83 | Tarsal synostosis (HP:0008368) | 1.69223071 |
| 84 | Muscle fiber atrophy (HP:0100295) | 1.67106422 |
| 85 | Limb-girdle muscle weakness (HP:0003325) | 1.65308610 |
| 86 | Foot dorsiflexor weakness (HP:0009027) | 1.64702361 |
| 87 | Facial diplegia (HP:0001349) | 1.63486894 |
| 88 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.58679068 |
| 89 | Rocker bottom foot (HP:0001838) | 1.56139832 |
| 90 | Heart block (HP:0012722) | 1.55000719 |
| 91 | Nonprogressive disorder (HP:0003680) | 1.54300916 |
| 92 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.51447599 |
| 93 | Synostosis involving bones of the feet (HP:0009140) | 1.51447599 |
| 94 | Abnormal atrioventricular conduction (HP:0005150) | 1.51053193 |
| 95 | Easy fatigability (HP:0003388) | 1.50356133 |
| 96 | Webbed neck (HP:0000465) | 1.48193770 |
| 97 | Neoplasm of the heart (HP:0100544) | 1.47019645 |
| 98 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.46652463 |
| 99 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.46652463 |
| 100 | Thin ribs (HP:0000883) | 1.46486539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.69434566 |
| 2 | PHKG2 | 5.47138095 |
| 3 | PHKG1 | 5.47138095 |
| 4 | PIK3CG | 3.72018700 |
| 5 | MAPK12 | 2.16994356 |
| 6 | EEF2K | 2.04418230 |
| 7 | OBSCN | 10.4050321 |
| 8 | MUSK | 1.90741178 |
| 9 | TRIB3 | 1.88361146 |
| 10 | MAP2K3 | 1.82402354 |
| 11 | MAPKAPK3 | 1.82188405 |
| 12 | MAP3K7 | 1.69232125 |
| 13 | NME1 | 1.48824434 |
| 14 | TRPM7 | 1.46276005 |
| 15 | PINK1 | 1.20038512 |
| 16 | MOS | 1.18462161 |
| 17 | CCNB1 | 1.11276356 |
| 18 | RIPK1 | 1.02160039 |
| 19 | MAP2K4 | 0.99379118 |
| 20 | DMPK | 0.98187564 |
| 21 | SIK1 | 0.95210561 |
| 22 | DYRK1B | 0.93697515 |
| 23 | MAP3K13 | 0.90816009 |
| 24 | MAP2K6 | 0.89514759 |
| 25 | LIMK1 | 0.89178901 |
| 26 | CAMK2G | 0.87699334 |
| 27 | MAPK7 | 0.87022072 |
| 28 | MAP3K10 | 0.81530345 |
| 29 | DDR2 | 0.79464650 |
| 30 | PRKAA2 | 0.74983490 |
| 31 | ICK | 0.73167920 |
| 32 | MARK1 | 0.72156165 |
| 33 | PRKAA1 | 0.65003449 |
| 34 | AKT2 | 0.64178243 |
| 35 | MAPK11 | 0.60794977 |
| 36 | NEK9 | 0.57126970 |
| 37 | KSR2 | 0.56528569 |
| 38 | MAPK4 | 0.55694228 |
| 39 | PIK3CA | 0.53125978 |
| 40 | LATS2 | 0.50969074 |
| 41 | RPS6KB2 | 0.49746567 |
| 42 | PRPF4B | 0.49383941 |
| 43 | MAP2K1 | 0.48527032 |
| 44 | MAPK15 | 0.48210825 |
| 45 | PRKG1 | 0.47865093 |
| 46 | NEK1 | 0.46716903 |
| 47 | MARK2 | 0.45868306 |
| 48 | CAMK4 | 0.45857550 |
| 49 | ERBB3 | 0.44514150 |
| 50 | EPHB1 | 0.40334473 |
| 51 | PDPK1 | 0.40142788 |
| 52 | ROCK1 | 0.39944216 |
| 53 | FGFR4 | 0.39550664 |
| 54 | TBK1 | 0.38311550 |
| 55 | TIE1 | 0.38228005 |
| 56 | MTOR | 0.37700174 |
| 57 | MAP3K1 | 0.37646571 |
| 58 | SGK3 | 0.36431470 |
| 59 | CAMK2D | 0.34825548 |
| 60 | PDGFRA | 0.34720661 |
| 61 | CAMK2B | 0.34635893 |
| 62 | CAMK1 | 0.34513815 |
| 63 | TAOK2 | 0.33970810 |
| 64 | TNK2 | 0.33815802 |
| 65 | ARAF | 0.33231947 |
| 66 | CAMK2A | 0.31182174 |
| 67 | RPS6KC1 | 0.31017899 |
| 68 | RPS6KL1 | 0.31017899 |
| 69 | RPS6KA2 | 0.30340772 |
| 70 | PKN1 | 0.28773105 |
| 71 | MAPK10 | 0.28060020 |
| 72 | PDK2 | 0.25319988 |
| 73 | RPS6KB1 | 0.24803076 |
| 74 | PKN2 | 0.24252624 |
| 75 | RPS6KA3 | 0.24140331 |
| 76 | CDC42BPA | 0.23722364 |
| 77 | PRKACA | 0.23619613 |
| 78 | MAP3K6 | 0.23122706 |
| 79 | PDK1 | 0.23082513 |
| 80 | ERN1 | 0.22654624 |
| 81 | RPS6KA1 | 0.22600192 |
| 82 | RPS6KA6 | 0.22138703 |
| 83 | SGK1 | 0.21706708 |
| 84 | IRAK2 | 0.21065726 |
| 85 | PRKD1 | 0.16652737 |
| 86 | ZAP70 | 0.15856994 |
| 87 | PRKD2 | 0.14972534 |
| 88 | PRKACB | 0.14783834 |
| 89 | MAP3K11 | 0.14531066 |
| 90 | LATS1 | 0.14473334 |
| 91 | SGK2 | 0.12669167 |
| 92 | CDK19 | 0.12574029 |
| 93 | ILK | 0.11483229 |
| 94 | TESK1 | 0.11127673 |
| 95 | RAF1 | 0.10978706 |
| 96 | MAP3K3 | 0.10858513 |
| 97 | BMX | 0.10683804 |
| 98 | MAPK8 | 0.09593879 |
| 99 | PRKG2 | 0.09205779 |
| 100 | MAP2K2 | 0.08340690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.97574358 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.53774759 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.05747951 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.90558539 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.15590319 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97587232 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.74821255 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.45807731 |
| 9 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.33799604 |
| 10 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.13012967 |
| 11 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 2.12811547 |
| 12 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.04866129 |
| 13 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.93863387 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 1.90842676 |
| 15 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.81239344 |
| 16 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.75629943 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.73743452 |
| 18 | Insulin resistance_Homo sapiens_hsa04931 | 1.68808347 |
| 19 | Tight junction_Homo sapiens_hsa04530 | 1.55079321 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53289883 |
| 21 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.49129443 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.47811956 |
| 23 | Focal adhesion_Homo sapiens_hsa04510 | 1.47589499 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46761128 |
| 25 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.45994405 |
| 26 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.29345354 |
| 27 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.28441939 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20124105 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18183499 |
| 30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12556647 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10606035 |
| 32 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.05819203 |
| 33 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00811114 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00788904 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99622505 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.95472867 |
| 37 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94857989 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.94105185 |
| 39 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.92552345 |
| 40 | * Gastric acid secretion_Homo sapiens_hsa04971 | 0.89612578 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 0.88181093 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87253658 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86131167 |
| 44 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81832346 |
| 45 | Parkinsons disease_Homo sapiens_hsa05012 | 0.79380319 |
| 46 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77572465 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76721827 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75823007 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70856093 |
| 50 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69826648 |
| 51 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69345077 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67797890 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66292622 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 0.63392450 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62396081 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62125658 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61266515 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58377206 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57964921 |
| 60 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55724090 |
| 61 | * Long-term potentiation_Homo sapiens_hsa04720 | 0.53904885 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53487213 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.53312914 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52641549 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51810546 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51542887 |
| 67 | * Renin secretion_Homo sapiens_hsa04924 | 0.49719157 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43867167 |
| 69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42212655 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.41371981 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41151998 |
| 72 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41126167 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39880394 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.39458420 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.39145172 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38899965 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37929725 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37122259 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36715092 |
| 80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36595230 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35230436 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34518055 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32635412 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.32452720 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30506444 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28274454 |
| 87 | * Salivary secretion_Homo sapiens_hsa04970 | 0.26181436 |
| 88 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25268685 |
| 89 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24260899 |
| 90 | * Glioma_Homo sapiens_hsa05214 | 0.24177883 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.24114439 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23293902 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22770075 |
| 94 | * Melanogenesis_Homo sapiens_hsa04916 | 0.22507156 |
| 95 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.22363293 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.21993833 |
| 97 | * Circadian entrainment_Homo sapiens_hsa04713 | 0.20490265 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19518731 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19127768 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.15424884 |

